Ondansetron HCL 8 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FCT4U
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $50,811
Award facts
- Contract value 100% obligated
- $50,811.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $50.8K delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 8 mg tablets (30-count) with a firm fixed price structure and a completion date of December 9, 2025. This non-set-aside, competitively awarded contract reflects AmerisourceBergen's ongoing role as a critical pharmaceutical vendor to federal medical procurement systems. The contract is executed as a child order under the company's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, leverages this prime contract vehicle to supply a broad spectrum of pharmaceutical products and medical commodities to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's demonstrated capability to fulfill federal medical supply requirements through open competition, combined with its extensive portfolio spanning generic and brand-name medications across multiple therapeutic domains, positions it as a strategic partner in the Defense Logistics Agency's pharmaceutical procurement strategy. This delivery order exemplifies the routine execution of the broader DLA Troop Support Medical contract framework, which enables flexible and scalable pharmaceutical distribution to military healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DR26FCT4U?
SPE2DR26FCT4U was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26FCT4U worth?
The government has obligated $50,811 on SPE2DR26FCT4U.
Is contract SPE2DR26FCT4U an order under another contract?
Yes. SPE2DR26FCT4U is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCT4U competed?
The extent of competition for SPE2DR26FCT4U was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award